Cambridge Technologies LLC – Trademark Portfolio
Entity Type: 16
Cambridge Technologies LLC holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 4 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 4 trademarks are registered and 1 is pending. Notable registered marks include SCORE, VERSA-DOSE, PRECISION SELECT, and PRECISION VACCINOLOGY. The owner is based in Worthington, MN.
1525 Bioscience Drive
Worthington, MN 56187
Showing of trademarks Trademarks
Trademark Classifications
Cambridge Technologies LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Cambridge Technologies LLC have?
Cambridge Technologies LLC has 6 U.S. trademarks filed with the USPTO. Of these, 4 registered, 1 pending, 1 abandoned.
What trademark classes does Cambridge Technologies LLC file in?
Cambridge Technologies LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Cambridge Technologies LLC's most well-known trademarks?
Cambridge Technologies LLC's registered trademark portfolio includes well-known marks such as SCORE, VERSA-DOSE, PRECISION SELECT, and PRECISION VACCINOLOGY. These are among 4 currently registered trademarks in the portfolio.
What is Cambridge Technologies LLC's trademark registration success rate?
Cambridge Technologies LLC has a 80% trademark registration rate, with 4 out of 5 resolved applications resulting in successful registration. Currently, 1 application is pending review.